ARC-520 Phase 1 | ARWR Message Board Posts

Arrowhead Pharmaceuticals, Inc.

  ARWR website

ARWR   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1667 of 8145  at  3/18/2014 5:24:17 PM  by

sooner_or_later55


ARC-520 Phase 1

I thought the Phase I on healthy volunters was over with 36 subjects.

Back on October 9, 2013 this was reported:
The study was planned to enroll 36 subjects in six cohorts of six subjects each, with 2 subjects receiving placebo and 4 receiving ARC-520. The study successfully enrolled all 36 subjects (24 received ARC-520, 12 placebo) at a single center in Melbourne, Australia. All subjects received their full, assigned dose and there were no discontinuations for adverse events or otherwise.

I see now they are saying Phase I is active with Estimated Enrollment of 48 on the Clinical Website. I may be incorrect but I thought the phase I was completed at the beginning of March but now I see it is still enrolling. Did I miss something and was it always planned to enroll 48 people? Hope someone that has followed this closer than I can clarify.

Thanks
Sooner


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 231
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
1668 Re: ARC-520 Phase 1 biochemyst 2 3/18/2014 5:44:15 PM
1676 Re: ARC-520 Phase 1 egomaniakos 4 3/19/2014 9:12:26 AM


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2016 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.

Loading...